Surface-enhanced Raman scattering enhancement using a hybrid gold nanoparticles@carbon nanodot substrate for herbicide detection.

The widespread distribution of herbicides in the environment poses a significant risk to human health and wildlife. Surface-enhanced Raman scattering (SERS) has emerged as a powerful technique for detecting and analyzing herbicides. However, developing a low-cost, highly sensitive, reproducible, stable, and Raman-active nanostructured substrate for herbicide detection remains a particular challenge. In this research, a nanohybrid substrate consisting of gold nanoparticles@carbon nanodots (AuNPs@CNDs) was synthesized by reducing HAuCl4 in the presence of CNDs at 100 °C. The optical, chemical, and physical properties of CNDs, AuNPs, and the hybrid AuNPs@CND substrates were thoroughly investigated using various techniques including UV-vis spectrometry, Raman spectroscopy, X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and CytoViva darkfield and hyperspectral imaging. The SERS effect of the substrates was evaluated using rhodamine 6G (Rh6G), a Raman-active probe, and two groups of herbicides containing mesotrione or S-metolachlor. The results demonstrated a significant signal amplification in the SERS spectra of Rh6G and herbicide molecule detection using the AuNPs@CND substrate compared to bare CNDs and AuNPs alone. This suggests that the nanohybrid AuNPs@CND SERS substrate holds promise for the detection of herbicides and other organic compounds in environmental applications.

A plasmonic nanoledge array sensor for detection of anti-insulin antibodies of type 1 diabetes biomarker.

Here we present a plasmonic nanoledge device with high sensitivity and selectivity used to detect protein biomarkers simply by functionalizing the device, which specifically binds to particular biomolecule or biomarkers. We employ this plasmonic nanoledge device for the detection of anti-insulin antibodies of type 1 diabetes (T1D) in buffer and human serum at the range of pg ml-1 to 100 ng ml-1. The signal transduction is based on the extraordinary optical transmission (EOT) through the nanoledge array and the optical spectral changes with the biological binding reaction between the surface functionalized insulin with anti-insulin antibody. Control experiments indicate little interferences from the human serum background and addition of other proteins such as bovine serum albumin (BSA) and epidermal growth factor (EGF) at 20 ng ml-1. The high sensitivity, specificity and easy adaptability of the plasmonic device offer new opportunities in biosensing and diagnostic applications for T1D.

A Plasmonic Nanoledge Array Sensor for Selective Detection of Cardiovascular Disease Biomarkers in Human Whole Blood.

Optical sensors face challenges when detecting ultralow amounts of analytes in whole blood, including signal quenching due to optical absorption and false positives due to nonspecific binding. This study introduces gold nanoscale array features termed nanoledges (NLs), which interact with incident white light to produce a transmitted surface plasmon resonance (tSPR) signal. This extraordinary optical transmission (EOT) spectrum occurs in the near-infrared (NIR) region, thereby minimizing signal quenching caused by visible-light absorption from blood proteins and pigments. To develop a sensitive, selective, and label-free optical biosensor for detecting various levels of cardiac troponin I (cTnI) in very small volumes of whole blood samples, DNA aptamers are tethered to the NL surface, specifically binding to the cTnI biomarker. This biological binding activity alters the refractive index at the NL surface, causing a peak shift in the EOT spectrum and enabling quantification of cTnI levels. The NL array chip demonstrated high sensitivity for cTnI detection in buffer, human serum (HS), and human whole blood (HB), with detection limits of 0.079, 0.084, and 0.097 ng/mL, respectively. Control measurements using blank target mediums and those containing up to 125 ng/mL of other proteins, such as myoglobin, creatine kinase, and heparin, showed minimal interference and high specificity. The NL plasmonic array's performance in biosensing underscores its promise for clinical analysis and its potential development as a point-of-care platform for early cardiovascular disease (CVD) diagnostics.

Advancements in mercury detection using surface-enhanced Raman spectroscopy (SERS) and ion-imprinted polymers (IIPs): a review.

Mercury (Hg) contamination remains a major environmental concern primarily due to its presence at trace levels, making monitoring the concentration of Hg challenging. Sensitivity and selectivity are significant challenges in the development of mercury sensors. Surface-enhanced Raman spectroscopy (SERS) and ion-imprinted polymers (IIPs) are two distinct analytical methods developed and employed for mercury detection. In this review, we provide an overview of the key aspects of SERS and IIP methodologies, focusing on the recent advances in sensitivity and selectivity for mercury detection. By examining the critical parameters and challenges commonly encountered in this area of research, as reported in the literature, we present a set of recommendations. These recommendations cover solid and colloidal SERS substrates, appropriate Raman reporter/probe molecules, and customization of IIPs for mercury sensing and removal. Furthermore, we provide a perspective on the potential integration of SERS with IIPs to achieve enhanced sensitivity and selectivity in mercury detection. Our aim is to foster the establishment of a SERS-IIP hybrid method as a robust analytical tool for mercury detection across diverse fields.

Plasmon-Exciton Coupling Effect in Nanostructured Arrays for Optical Signal Amplification and SARS-CoV-2 DNA Sensing.

A surface plasmon resonance (SPR)-enhanced optical signal using a nanoslit array and acridine orange (AO) dye system at a flexible poly(dimethylsiloxane) (PDMS) substrate was achieved in this work and demonstrated a simple sensing scheme to directly detect SARS-CoV-2 nucleic acid via DNA hybridization. A simple nanoimprinting pattern transfer technique was introduced to form uniform reproducible nanoslit arrays where the dimensions of the slit array were controlled by the thickness of the gold film. The plasmon-exciton coupling effect on the optical enhancement of different dye molecules, i.e., AO, propidium iodide (PI), or dihydroethidium (DHE) attached to the nanoslit surfaces, was examined thoroughly by measuring the surface reflection and fluorescence imaging. The results indicate that the best overlap of the plasmon resonance wavelength to the excitation spectrum of AO presented the largest optical enhancement (∼57×) compared to the signal at flat gold surfaces. Based on this finding, a sensitive assay for detecting DNA hybridization was generated using the interaction of the selected SARS-CoV-2 ssDNA and dsDNA with AO to trigger the metachromatic behavior of the dye at the nanoarray surfaces. We found strong optical signal amplification on the formation of acridine-ssDNA complexes and a quenched signal upon hybridization to the complementary target DNA (ct-DNA) along with a blue shift in the fluorescence of AO-dsDNAs. A quantitative evaluation of the ct-DNA concentration in a range of 100-0.08 nM using both the reflection and emission imaging signals demonstrated two linear regimes with a lowest detection limit of 0.21 nM. The sensing method showed high sensitivity and distinguished signals from 1-, 2-, and 3-base mismatched DNA targets, as well as high stability and reusability. This approach toward enhancing optical signal for DNA sensing offers promise in a general, rapid, and direct vision detection method for nucleic acid analytes.